Keywords: pdl, zamyl, mixed, results, phase, iii, acute

PDL's Zamyl has mixed results in Phase III acute myeloid leukemia trial

Article | 10 December 2001

Print This

Protein Design Labs has reported what it says are positive results froma Phase III trial of its candidate ther_apy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in